Cargando…
STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting
Autores principales: | Plucinski, Mateusz, Ashley, Elizabeth A., Bassat, Quique, Venkatesan, Meera, Rosenthal, Philip J., Halsey, Eric S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294688/ https://www.ncbi.nlm.nih.gov/pubmed/35880678 http://dx.doi.org/10.4269/ajtmh.22-0224 |
Ejemplares similares
-
STARTER checklist for antimalarial therapeutic efficacy reporting
por: Plucinski, Mateusz M., et al.
Publicado: (2022) -
Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
por: Plucinski, Mateusz M., et al.
Publicado: (2019) -
Split dosing of artemisinins does not improve antimalarial therapeutic efficacy
por: White, N. J., et al.
Publicado: (2017) -
Making sense of emerging evidence on the non-specific effects of the BCG vaccine on malaria risk and neonatal mortality
por: Bassat, Quique, et al.
Publicado: (2020) -
Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network
por: Halsey, Eric S., et al.
Publicado: (2017)